• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病可穿戴传感器检测临床无识别的清晨运动不能症的 Kinetigraph:基于病例报告的观察。

Parkinson's Kinetigraph for Wearable Sensor Detection of Clinically Unrecognized Early-Morning Akinesia in Parkinson's Disease: A Case Report-Based Observation.

机构信息

Department of Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 9RX, UK.

出版信息

Sensors (Basel). 2024 May 11;24(10):3045. doi: 10.3390/s24103045.

DOI:10.3390/s24103045
PMID:38793900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11125273/
Abstract

Early-morning off periods, causing early-morning akinesia, can lead to significant motor and nonmotor morbidity in levodopa-treated fluctuating Parkinson's disease (PD) cases. Despite validated bedside scales in clinical practice, such early-morning off periods may remain undetected unless specific wearable technologies, such as the Parkinson's KinetiGraph™ (PKG) watch, are used. We report five PD cases for whom the PKG detected early-morning off periods that were initially clinically undetected and as such, untreated. These five cases serve as exemplars of this clinical gap in care. Post-PKG assessment, clinicians were alerted and targeted therapies helped abolish the early-morning off periods.

摘要

清晨无活动期导致清晨运动不能,可导致左旋多巴治疗的帕金森病(PD)波动患者出现显著的运动和非运动并发症。尽管在临床实践中有经过验证的床边量表,但除非使用特定的可穿戴技术(如帕金森 KinetiGraph™(PKG)手表),否则可能会漏诊这些清晨无活动期。我们报告了五例 PD 病例,这些病例的 PKG 检测到了临床上最初未检测到的清晨无活动期,因此未得到治疗。这五个病例是这种护理临床空白的典型例子。在 PKG 评估后,临床医生得到了提醒,并采用靶向治疗来消除清晨无活动期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c9/11125273/f1ecdf2b6dfa/sensors-24-03045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c9/11125273/f1ecdf2b6dfa/sensors-24-03045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0c9/11125273/f1ecdf2b6dfa/sensors-24-03045-g001.jpg

相似文献

1
Parkinson's Kinetigraph for Wearable Sensor Detection of Clinically Unrecognized Early-Morning Akinesia in Parkinson's Disease: A Case Report-Based Observation.帕金森病可穿戴传感器检测临床无识别的清晨运动不能症的 Kinetigraph:基于病例报告的观察。
Sensors (Basel). 2024 May 11;24(10):3045. doi: 10.3390/s24103045.
2
Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.帕金森运动图与开/关左旋多巴反应测试的比较:单中心经验。
Clin Neurol Neurosurg. 2021 Oct;209:106890. doi: 10.1016/j.clineuro.2021.106890. Epub 2021 Aug 13.
3
Prediction of the Levodopa Challenge Test in Parkinson's Disease Using Data from a Wrist-Worn Sensor.基于腕戴式传感器数据预测帕金森病患者的左旋多巴挑战试验。
Sensors (Basel). 2019 Nov 25;19(23):5153. doi: 10.3390/s19235153.
4
Early-morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using Time-to-ON Questionnaire.在常规临床就诊中,使用“开期时间问卷”评估帕金森病患者清晨关期和左旋多巴剂量失败的情况。
Eur J Neurol. 2019 May;26(5):821-826. doi: 10.1111/ene.13895. Epub 2019 Jan 28.
5
Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experience.基于传感器的算法剂量建议,用于帕金森病患者口服左多巴/卡比多巴微丸:初步经验。
J Neurol. 2019 Mar;266(3):651-658. doi: 10.1007/s00415-019-09183-6. Epub 2019 Jan 18.
6
Predicting Motor Outcome and Quality of Life After Subthalamic Deep Brain Stimulation for Parkinson's Disease: The Role of Standard Screening Measures and Wearable-Data.预测帕金森病患者接受丘脑底核深部脑刺激后的运动结局和生活质量:标准筛查措施和可穿戴数据的作用。
J Parkinsons Dis. 2023;13(4):575-588. doi: 10.3233/JPD-225101.
7
Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.帕金森氏 KinetiGraph 的成本效益分析及其在帕金森病管理中的临床评估。
J Med Econ. 2022 Jan-Dec;25(1):774-782. doi: 10.1080/13696998.2022.2080437.
8
Comparing subjective and objective response to medications in Parkinson's disease patients using the Personal KinetiGraph™.使用个人运动监测仪(Personal KinetiGraph™)比较帕金森病患者对药物的主观和客观反应。
Parkinsonism Relat Disord. 2021 Jun;87:105-110. doi: 10.1016/j.parkreldis.2021.05.008. Epub 2021 May 11.
9
Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson's disease: recommendations from an expert panel.个人运动描记器在帕金森病常规临床评估中的作用:专家小组的建议。
Expert Rev Neurother. 2018 Aug;18(8):669-680. doi: 10.1080/14737175.2018.1503948. Epub 2018 Jul 26.
10
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.帕金森病中运动性和非运动性剂末现象的识别:患者问卷与临床医生评估的比较
Mov Disord. 2005 Jun;20(6):726-33. doi: 10.1002/mds.20383.

引用本文的文献

1
Test, track, treat using wearable sensors for management of Parkinson's disease: 12‑month prospective observational United Arab Emirates study using Parkinson's Kinetograph (EmPark-PKG Study).使用可穿戴传感器进行帕金森病管理的检测、追踪、治疗:在阿拉伯联合酋长国进行的为期12个月的帕金森病动态监测仪前瞻性观察研究(EmPark-PKG研究)
J Neural Transm (Vienna). 2025 Apr;132(4):591-601. doi: 10.1007/s00702-024-02873-0. Epub 2024 Dec 27.
2
Non-Motor Fluctuations in Parkinson's Disease: Underdiagnosed Yet Important.帕金森病的非运动波动:诊断不足但很重要。
J Mov Disord. 2025 Jan;18(1):1-16. doi: 10.14802/jmd.24227. Epub 2024 Dec 20.
3

本文引用的文献

1
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.帕金森病患者皮下持续输注左旋多巴/卡比多巴:一项为期12个月的单臂、开放标签3期研究的安全性和有效性结果
Neurol Ther. 2023 Dec;12(6):1937-1958. doi: 10.1007/s40120-023-00533-1. Epub 2023 Aug 26.
2
Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.左旋多巴诱导的帕金森病运动障碍:发病机制与新兴治疗策略。
Cells. 2022 Nov 23;11(23):3736. doi: 10.3390/cells11233736.
3
Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
Addressing the Ethnicity Gap in Catechol O-Methyl Transferase Inhibitor Trials in Parkinson's Disease: A Review of Available Global Data.
解决帕金森病中儿茶酚-O-甲基转移酶抑制剂试验中的种族差异:对现有全球数据的综述
J Pers Med. 2024 Sep 3;14(9):939. doi: 10.3390/jpm14090939.
帕金森氏 KinetiGraph 的成本效益分析及其在帕金森病管理中的临床评估。
J Med Econ. 2022 Jan-Dec;25(1):774-782. doi: 10.1080/13696998.2022.2080437.
4
Does good sleep reduce early-morning off periods in patients with Parkinson's disease?良好的睡眠能否减少帕金森病患者的清晨关期?
Sleep. 2020 Aug 12;43(8). doi: 10.1093/sleep/zsaa020.
5
Early morning off in patients with Parkinson's disease: a Chinese nationwide study and a 7-question screening scale.早间发作的帕金森病患者:一项中国全国性研究和一个 7 问筛查量表。
Transl Neurodegener. 2020 Jul 6;9(1):29. doi: 10.1186/s40035-020-00208-z.
6
The Use of Data from the Parkinson's KinetiGraph to Identify Potential Candidates for Device Assisted Therapies.利用帕金森氏症动力学图的数据来识别潜在的器械辅助治疗候选者。
Sensors (Basel). 2019 May 15;19(10):2241. doi: 10.3390/s19102241.
7
Impact of Quantitative Assessment of Parkinson's Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions.使用可穿戴技术对帕金森病相关症状进行定量评估对治疗决策的影响。
J Parkinsons Dis. 2019;9(3):601. doi: 10.3233/JPD-191623.
8
Early-morning OFF and levodopa dose failures in patients with Parkinson's disease attending a routine clinical appointment using Time-to-ON Questionnaire.在常规临床就诊中,使用“开期时间问卷”评估帕金森病患者清晨关期和左旋多巴剂量失败的情况。
Eur J Neurol. 2019 May;26(5):821-826. doi: 10.1111/ene.13895. Epub 2019 Jan 28.
9
The use of accelerometry as a tool to measure disturbed nocturnal sleep in Parkinson's disease.将加速度计用作测量帕金森病患者夜间睡眠紊乱的工具。
NPJ Parkinsons Dis. 2018 Jan 10;4:1. doi: 10.1038/s41531-017-0038-9. eCollection 2018.
10
An Ambulatory Tremor Score for Parkinson's Disease.帕金森病的动态震颤评分
J Parkinsons Dis. 2016 Oct 19;6(4):723-731. doi: 10.3233/JPD-160898.